Pembrolizumab

Results: 8



#Item
1When Patients Win, We All Win™  Provectus Biopharmaceuticals, Inc Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigation

When Patients Win, We All Win™ Provectus Biopharmaceuticals, Inc Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigation

Add to Reading List

Source URL: www.pvct.com

Language: English - Date: 2016-08-18 16:04:23
224 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box

24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box

Add to Reading List

Source URL: www.nzma.org.nz

Language: English - Date: 2016-05-25 01:37:50
312-AUG:10 CANCER CONTROL ACCRUAL REPORT STUDY  O

12-AUG:10 CANCER CONTROL ACCRUAL REPORT STUDY O

Add to Reading List

Source URL: www.swogstat.org

Language: English - Date: 2016-08-19 21:10:17
412 JulyGeraldine MacGibbon Senior Therapeutic Group Manager PHARMAC PO Box

12 JulyGeraldine MacGibbon Senior Therapeutic Group Manager PHARMAC PO Box

Add to Reading List

Source URL: www.nzma.org.nz

Language: English - Date: 2016-07-11 21:31:12
5Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma

Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma

Add to Reading List

Source URL: www.immunotherapyofcancer.org

Language: English
6James A. Schlipmann Melanoma Cancer Foundation / Melanoma / Cancer organizations / AIM at Melanoma Foundation

MELANOMA PATIENTS AUSTRALIA SUBMISSION PBAC consideration of KEYTRUDA (pembrolizumab) Background of Melanoma Patients Australia (MPA) MPA is the only patient driven not for profit organisation in Australia that offers a

Add to Reading List

Source URL: www.melanomapatients.org.au

Language: English - Date: 2015-02-19 18:52:21
7HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KEYTRUDA safely and effectively. See full prescribing information for KEYTRUDA. KEYTRUDA® (pembrolizumab) for injec

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KEYTRUDA safely and effectively. See full prescribing information for KEYTRUDA. KEYTRUDA® (pembrolizumab) for injec

Add to Reading List

Source URL: www.merck.com

Language: English - Date: 2014-09-04 16:42:45
8KEYTRUDA® (pembrolizumab) for injection

KEYTRUDA® (pembrolizumab) for injection

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-09-10 08:55:29